Politics
US Warns of Chinese Medicine Dominance
The U.S. is concerned about China's growing control over the global medicine supply chain and calls for action to protect domestic leadership in biomedical industries.
Coverage timeline — 1 article
The Hill
China is using economic leverage to dominate the global supply chain for medicines, and the U.S. must take action to protect its leadership in the biomedical industry by strengthening regulatory frameworks and investing in domestic infrastructure.
2026-06-15 17:00 UTC